Top

Supportive Care in Cancer

Published in:

01-10-2017 | Original Article

Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications

Published in: Supportive Care in Cancer | Issue 10/2017

Title: Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications
Publication date: 01-10-2017
Published in: Supportive Care in Cancer / Issue 10/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3726-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2017

Return-to-work outcomes in cancer survivors

Mindfulness-based stress reduction for breast cancer patients: a mixed method study on what patients experience as a suitable stage to participate

Reported distress in patients living with advanced cancer: changes pre-post interdisciplinary palliative rehabilitation

Integration of oncology and palliative care: setting a benchmark

Feeding strategies in pediatric cancer patients with gastrointestinal mucositis: a multicenter prospective observational study and international survey

Associations of sleep disturbance with physical function and cognition in older adults with cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer